Canada grants Frutarom product license for Benolea

Canada grants Frutarom product license for Benolea

Product license is for a recommended use in support of cardiovascular health by maintaining healthy blood pressure levels.

The Canadian Natural Health Products Directorate (NHPD) granted Frutarom, a product license for its Benolea® cardiovascular health support ingredient. Benolea supports cardiovascular health by maintaining healthy blood pressure levels. A recent clinical study by Endang Susalit, PhD, et al, showed that extract of olive leaf (Olea europaea) was effective in patients with stage-1 hypertension, demonstrating that Benolea can lower blood pressure. As of December, Benolea, manufactured in Wadinswil, Switzerland, using Frutarom’s proprietary HyperPure process, will be available to local dietary supplement manufacturers in Canada.

Benolea will be marketed in Canada by CK Ingredients, an Ontario, Canada-based distributor of specialty food and supplement ingredients.

Since ancient times, olive leaves have been used for medicinal purposes, exhibiting a wide range of activity, especially for cardiovascular health. Benolea offers the health benefit of olive leaves in a very convenient form for dietary supplement manufacturers

“We are excited to receive the Products Licence for Benolea® from The Canadian Natural Health Products Directorate (NHPD),” says Yannick Capelle, product manager for Frutarom Health. “Benolea is already marketed successfully as dietary supplements successful sold in the U.S., Germany, Finland and Bulgaria. We are confident Canada may now also benefit from the introduction of similar products.”

 

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish